Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreren
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PFIZER, INC.

(PFE)
  Rapport
Vertraagde tijd Nyse  -  21:03:09 21-03-2023
40.66 USD   -0.37%
21/03Amerikaanse FDA beslist binnenkort over tweede ronde boosters op maat van Omicron - WSJ
MR
17/03Pfizer, Inc. : Wells Fargo Securities handhaaft het Neutraal advies
MM
17/03Humanwell Healthcare krijgt groen licht voor onderzoek naar anti-epileptica voor de behandeling van epilepsie
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť PFIZER, INC.
21/03Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analy..
BU
21/03Mainz Biomed ($MYNZ) Inks Accretive Partnership To Expand Marketing Reach Of ColoAlert..
AQ
17/03FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer's ..
AQ
16/03Advisory panel recommends full FDA approval for COVID-19 medication Paxlovid
AQ
16/0319 pill Paxlovid moves closer to full FDA approval
AQ
16/0319 pill Paxlovid moves closer to full FDA approval
AQ
16/03FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer's ..
BU
16/03Shares Of Inhibikase Therapeutics Stock Decouples From NASDAQ Weakness; Jump 8% Includi..
AQ
16/03Pfizer : 2022 ESG Report
PU
16/03Laos, Malawi, Rwanda and Zambia Have Received Oral Antiviral Treatments for High-Risk P..
AQ
16/03Fitch Revises Pfizer's Outlook to Stable; Affirms IDR at 'A'
AQ
16/03Pfizer acquires Seagen for 43 billion USD
AQ
15/03FDA panel to consider full approval of Pfizer's COVID-19 drug Paxlovid
AQ
15/03In The Queue : AcurX Pharmaceuticals Earnings...Here's What Investors Need To Know Before ..
AQ
14/03Astellas Announces Phase 3 China ARCHES Study of XTANDI Meets Primary Endpoint
AQ
14/03Pfizer to acquire Seagen for $43 billion
AQ
14/03Inhibikase Therapeutics Stock Turns Bullish After FDA Lifts Full Clinical Hold For Lead..
AQ
13/03Pfizer pays $43 billion to buy cancer-fighting biotech company Seagen
AQ
13/03Pfizer buys Seagen for $43B, boosts access to cancer drugs
AQ
13/03Pfizer's ZAVZPRET Migraine Nasal Spray Receives FDA Approval
AQ
13/03Pfizer Inc : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other E..
AQ
13/03Pfizer : Press Release
PU
13/03Pfizer Invests $43 Billion to Battle Cancer
BU
13/03Pfizer Invests $43 Billion to Battle Cancer
BU
10/03FDA approves Pfizer's nasal spray zavegepant for migraines
AQ
10/03Pfizer's ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval
BU
07/03Mainz Biomed In Focus Ahead Of Two Data-Set Releases In 1H/2023 ($MYNZ)
AQ
06/03Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma
AQ
03/03Keeping IP Under Lock And Key
AQ
03/03Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma
AQ
01/03DelveInsight Evaluates a Robust Oligodendroglioma Pipeline as 10+ Influential Pharma Pl..
AQ
28/02FDA panel narrowly backs Pfizer RSV vaccine for older adults
AQ
28/02Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for..
BU
28/02Mainz Biomed's Milestones Reached In 2022 Can Be Catalysts In 1/H 2023...Here's Why ($M..
AQ
27/02Brazil Covid Vaccine
AQ
27/02Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare ..
BU
23/02PFIZER INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
23/02Pfizer's Elranatamab Receives FDA and EMA Filing Acceptance
AQ
23/02New booster plan in time for winter
AQ
22/02U.S. FDA Accepts Biologics License Application for Pfizer's Respiratory Syncytial Virus..
AQ
22/02Genentech BPCIA Trastuzumab Case Against Tanvez Dismissed After Settlement
AQ
22/02Pfizer's Elranatamab Receives FDA and EMA Filing Acceptance
BU
21/02Pfizer : 8-K Feb 21 2023 - Form 8-K
PU
21/02Pfizer Inc : Other Events (form 8-K)
AQ
21/02FDA weighing approval for RSV vaccine for infants, will decide this summer
AQ
21/02Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness..
AQ
21/02Race To The Cure : Here's Why Acurx Pharmaceuticals Could Win The Battle To Treat C. diffi..
AQ
21/02U.S. FDA Accepts Biologics License Application for Pfizer's Respiratory Syncytial Virus..
BU
20/02Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme disease Vacci..
AQ
17/02NHI Bill Must Still Clear Many Hurdles to Ensure Adequate Medicine Access
AQ
17/02Pfizer Announces Positive TALZENNA and XTANDI Combination Data from Phase 3 TALAPRO-2 S..
AQ
17/02Bristol Myers Squibb - Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Camp..
AQ
16/02Pfizer Announces Positive TALZENNAģ and XTANDIģ Combination Data from Phase 3 TALAPRO-2..
BU
16/02Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the..
BU
13/02FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO
AQ
13/02Pfizer and BioNTech mRNA shingles vaccine study begins
AQ
13/02Lucy Scientific Discovery, Inc.'s Health Canada License Accelerates Mission To Make Psy..
AQ
10/02FDA Approves Pfizer's Supplemental New Drug Application for CIBINQOģ (abrocitinib)
BU
10/02Lucy Scientific Discovery, Inc. - A NASDAQ Listed Psychedelics-Based Therapeutics Compa..
AQ
09/02Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conferenc..
BU
09/02Awakn Life Sciences Corp Shares Rally 77% After Earning ILAP Expedited Approval Pathway..
AQ
09/02Supreme Court Denies Review Of Cost Sharing Assistance Program
AQ
07/02Awakn Life Sciences Corp Earns Global AUD Treatment Interest With A New Class Of Psyche..
AQ
02/02Avalon GloboCare Partnerships, Completed Capital Raise, And Robust IP Portfolio Expose ..
AQ
01/02First To File : Issue 9
AQ
01/02MassBio - Pfizer Pharma Day to ignite breakthrough partnerships
AQ
31/01Drugmaker Pfizer starts low with 2023 earnings forecast
AQ
31/01Pfizer : Q4 Earnings Snapshot
AQ
31/01With Multiple Shots On Revenue-Generating Goals, Avalon GloboCare Positions For A Break..
AQ
31/01Pfizer : Fourth Quarter 2022 Press Release
PU
31/01Pfizer reports record full-year 2022 results and provides full-year 2023 financial guid..
BU
27/01FDA's advisers back plan to simplify COVID-19 vaccinations
AQ
24/01Avalon GloboCare Strengthens IP Portfolio, Earns Breakthrough Patent For QTY-Code Techn..
AQ
24/01Avalon GloboCare Scores Patent For Breakthrough QTY-Code Technology To Expedite Develop..
AQ
19/01Longevity Biotech Gero Entered a Research Collaboration With Pfizer to Discover Potenti..
AQ
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op PFIZER, INC.